Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations and methods of use for alpha connexin c-terminal (ACT) peptides

Formulations and methods of use for alpha connexin c-terminal (ACT) peptides

US Patent 11524049 · Granted Dec 13, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Peptide formulations and ophthalmic uses thereof2024
Formulations and methods of use for alpha connexin c-terminal (ACT) peptides2024
Formulations and methods of use for alpha connexin C-terminal (ACT) peptides2020
Alpha connexin C-terminal (ACT) peptides and methods of use thereof2019
Alpha connexin c-terminal (ACT) peptides and methods of use thereof2019
Compositions and methods for promoting wound healing and tissue regeneration2018
Alpha connexin C-terminal (ACT) peptides for use in transplant2017
Alpha Connexin c-Terminal (ACT) peptides for use in transplant2016
Compositions and methods for promoting wound healing and tissue regeneration2016
Formulations and methods of use for alpha connexin C-terminal (ACT) peptides2015
Compositions and methods for promoting wound healing and tissue regeneration2014
Compositions and methods for promoting wound healing and tissue regeneration2014